---
title: "Definium Therapeutics Grants Stock Options to New Employees"
description: "Definium Therapeutics Inc. has granted stock options to two new non-executive employees, totaling 28,640 common shares. The options, effective February 2, 2026, will vest over four years, with 25% ves"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/274556995.md"
published_at: "2026-02-02T21:00:25.000Z"
---

# Definium Therapeutics Grants Stock Options to New Employees

> Definium Therapeutics Inc. has granted stock options to two new non-executive employees, totaling 28,640 common shares. The options, effective February 2, 2026, will vest over four years, with 25% vesting on the first anniversary and the remaining 75% in monthly increments. The exercise price is based on the closing price of the shares on the grant date. This announcement was published via Business Wire and is for informational purposes only.

Definium Therapeutics Inc. has announced the issuance of inducement grants to two newly hired non-executive employees. The grants consist of options to purchase a total of 28,640 common shares, with an effective grant date of February 2, 2026. The options will vest over four years: 25% will vest on the first anniversary of the grant date, and the remaining 75% will vest in equal monthly increments over the subsequent three years. The exercise price for the options is set at the closing price of Definium’s common shares on the grant date. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Definium Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260202023136) on February 02, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [DFTX.US - Definium Therapeutics](https://longbridge.com/en/quote/DFTX.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Definium Therapeutics Appoints Roger Adsett to Board of Directors | Definium Therapeutics Inc. has appointed Roger Adsett to its Board of Directors. Adsett has over 20 years of experience  | [Link](https://longbridge.com/en/news/274145221.md) |
| Definium Therapeutics Grants Stock Options to New Employees | Definium Therapeutics Inc. has granted stock options to three new non-executive employees, totaling 88,850 common shares | [Link](https://longbridge.com/en/news/273745776.md) |
| Definium Therapeutics Adds Commercial Leader As Phase 3 Milestones Approach | Definium Therapeutics has appointed Roger Adsett, a seasoned biopharmaceutical executive, to its Board of Directors as i | [Link](https://longbridge.com/en/news/274377675.md) |
| TEAMZ Summit 2026 – Title and Gold Sponsorships Sold Out Quickly | TEAMZ Co., Ltd. announced that all Title and Gold sponsorships for the "TEAMZ Summit 2026" have sold out, with only 1 Pl | [Link](https://longbridge.com/en/news/276701561.md) |
| Bitwise: DeFi may lead us out of the crypto winter | Bitwise's Chief Investment Officer, Matt Hougan, highlights the potential of DeFi to emerge from the current crypto bear | [Link](https://longbridge.com/en/news/276577899.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.